Answers are grounded in this paper and cite their sources.
Amputations in diabetic foot is a last-resort treatment when conservative options like wound care and medications have proven it difficult to treat. Mortality, re-operations, and re-amputations are clinical outcomes that greatly affect patients and should be studied thoroughly; however, data is reported sporadically. This review aims to collate the mortality and re-amputation rates in major amputations for diabetic foot disease. A literature search of PubMed, EMBASE, and MEDLINE from inception until May 2026 was undertaken for studies reporting mortality, re-amputation, and/or re-operation rate after amputations in diabetic foot disease and screened according to PRISMA guidelines. 88 studies with 303,732 patients (304,476 feet) were included, with a mean age of 64.75 years. Mortality in major amputations at 30-day, 1-year, 3-year, 5-year, and 10-year are 11.01%, 36.06%, 47.33%, 69.35%, and 82.01%, respectively. Re-amputation rates in major amputations are 7.20% at 6 months, and 18.26% at 1 year. Weighted mean overall mortality rates were 5.68% at 30 days, 20.18% at 1 year, 45.64% at 3 years, 55.47% at 5 years, and 65.74% at 10 years. Re-amputation rates at 30-day, 1-year, 3-year, and 10-year are 10.98%, 23.82%, 26.53%, and 23.11% respectively. This review notes a high overall mortality in amputations of diabetic foot. Our review reports higher rates than previous reviews, possibly from the increased number of patients reported in our updated review. Further studies should explore the long-term outcomes to provide a stronger analysis of long-term data.
No takes yet. Share an insight, caveat, or question.
Chan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: